Abbott Laboratories (ABT) Tops Q2 EPS by 5c; Guides Above
More News related to ABT
- Absolute Helps Police Break Possible Identity Theft Ring
- Absolute's Computrace Included in a Major Computer Manufacturer's Customer Care Program
- Johnson & Johnson's (JNJ) Wins $1.67B Patent Verdict Versus Abbott Laboratories (ABT)
- Absolute Software Exhibiting at National Education Computing Conference (NECC) 2009
- Abbott Hosts Conference Call for Second-Quarter Earnings
Abbott Laboratories (NYSE: ABT) reports Q2 EPS of $0.84, versus the consensus of $0.79. Revenues came in at $7.31 billion, versus the consensus of $7.23 billion.
Sees Q3 EPS of $0.76-$0.78, versus the consensus of $0.79.
Sees FY EPS of $3.24-$3.28, versus the consensus of $3.23.
Related Categories
EarningsGuidance
Hot List
Stocks Mentioned
-21.60Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
